I talk to Robin Carhart Harris about an important tool of the future: psychedelics. Robin has the aura of your typical “cool scientist” and heads the Psychedelic Research Group within the Centre for Psychiatry at Imperial College London. He has designed a number of functional brain imaging studies with psilocybin, LSD, MDMA and DMT, plus a clinical trial of psilocybin for treatment resistant depression. Carhart-Harris is the first person in the UK to have legally administered doses of LSD to human volunteers since the Misuse of Drugs Act of 1971. He is passionate about finding proof, that we need new mental health drugs.
